Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.87
+0.22 (1.77%)
At close: Jun 18, 2026, 4:00 PM EDT
12.91
+0.04 (0.28%)
After-hours: Jun 18, 2026, 4:10 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $915.32 million as of June 18, 2026. Its market cap has increased by 14.93% in one year.
Market Cap
915.32M
Enterprise Value
861.63M
1-Year Change
14.93%
Ranking
Category
Stock Price
$12.87
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $915.32M, an increase of 610.35%. That is a compound annual growth rate of 7.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 915.32M | -20.21% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 957.74M |
| Sana Biotechnology | 944.68M |
| Xencor | 937.15M |
| SL Science Holding | 935.81M |
| Cullinan Therapeutics | 923.71M |
| Odyssey Therapeutics | 899.61M |
| Arbutus Biopharma | 898.80M |
| Lexicon Pharmaceuticals | 892.83M |